JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1677/joe.0.1720411

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (91)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pritchard, L.
Right arrow Articles by White, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pritchard, L.
Right arrow Articles by White, A
Journal of Endocrinology, Vol 172, Issue 3, 411-421
Copyright © 2002 by Society for Endocrinology


Articles

Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity

LE Pritchard, AV Turnbull, and A White


Bioactive peptides derived from the prohormone, pro-opiomelanocortin (POMC), are generated in neurons of the hypothalamus and act as endogenous ligands for the melanocortin-4 receptor (MC4R), a key molecule underlying appetite control and energy homeostasis. It is therefore important to understand many aspects of POMC gene regulation in the brain, as pharmacological manipulation of POMC expression/processing could be a potential strategy to combat obesity. Most studies that have analysed POMC gene expression in the hypothalamus have focused on gene transcription experiments. Ultimately, however, factors that regulate post-translational processing and secretion of peptides will have most bearing on melanocortin signalling. This article focuses on (a) current evidence that POMC is involved in obesity, (b) how POMC transcription is regulated in the hypothalamus, (c) the mechanism by which proteolytic processing of POMC is controlled in the hypothalamus and what peptides are produced and (d) which POMC-derived peptides are the most potent ligands at the melanocortin receptor in vitro and in vivo. It seems that post-translational cleavage of POMC in the hypothalamus may be regulated with respect to energy requirement. We predict that further research into hypothalamic POMC processing, and the proteolytic enzymes involved, may yield important new clues on how flux through the MC4R pathway is regulated.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. W. M. Creemers, Y. S. Lee, R. L. Oliver, M. Bahceci, A. Tuzcu, D. Gokalp, J. Keogh, S. Herber, A. White, S. O'Rahilly, et al.
Mutations in the Amino-Terminal Region of Proopiomelanocortin (POMC) in Patients with Early-Onset Obesity Impair POMC Sorting to the Regulated Secretory Pathway
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4494 - 4499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. K. Song, C. H. Vaughan, E. Keen-Rhinehart, R. B. S. Harris, D. Richard, and T. J. Bartness
Melanocortin-4 receptor mRNA expressed in sympathetic outflow neurons to brown adipose tissue: neuroanatomical and functional evidence
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R417 - R428.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H Rumie, L A Metherell, A J L Clark, V Beauloye, and M Maes
Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein
Eur. J. Endocrinol., October 1, 2007; 157(4): 539 - 542.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. E. Pritchard and A. White
Neuropeptide Processing and Its Impact on Melanocortin Pathways
Endocrinology, September 1, 2007; 148(9): 4201 - 4207.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. A. Nillni
Regulation of Prohormone Convertases in Hypothalamic Neurons: Implications for ProThyrotropin-Releasing Hormone and Proopiomelanocortin
Endocrinology, September 1, 2007; 148(9): 4191 - 4200.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. E. Scholzen, S. Konig, M. Fastrich, M. Bohm, and T. A. Luger
Terminating the Stress: Peripheral Peptidolysis of Proopiomelanocortin-Derived Regulatory Hormones by the Dermal Microvascular Endothelial Cell Extracellular Peptidases Neprilysin and Angiotensin-Converting Enzyme
Endocrinology, June 1, 2007; 148(6): 2793 - 2805.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. Rousseau, S. Kauser, L. E. Pritchard, A. Warhurst, R. L. Oliver, A. Slominski, E. T. Wei, A. J. Thody, D. J. Tobin, and A. White
Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis
FASEB J, June 1, 2007; 21(8): 1844 - 1856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Perello, R. C. Stuart, and E. A. Nillni
Differential effects of fasting and leptin on proopiomelanocortin peptides in the arcuate nucleus and in the nucleus of the solitary tract
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1348 - E1357.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
H. Shimizu, K. Inoue, and M. Mori
The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure
J. Endocrinol., April 1, 2007; 193(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. C. L. Tung, S. J. Piper, D. Yeung, S. O'Rahilly, and A. P. Coll
A Comparative Study of the Central Effects of Specific Proopiomelancortin (POMC)-Derived Melanocortin Peptides on Food Intake and Body Weight in Pomc Null Mice
Endocrinology, December 1, 2006; 147(12): 5940 - 5947.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. A. Sebag and P. M. Hinkle
Regulation of Endogenous Melanocortin-4 Receptor Expression and Signaling by Glucocorticoids
Endocrinology, December 1, 2006; 147(12): 5948 - 5955.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. J. Lloyd, S. Bohan, and N. Gekakis
Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice
Hum. Mol. Genet., June 1, 2006; 15(11): 1884 - 1893.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. W. M. Creemers, L. E. Pritchard, A. Gyte, P. Le Rouzic, S. Meulemans, S. L. Wardlaw, X. Zhu, D. F. Steiner, N. Davies, D. Armstrong, et al.
Agouti-Related Protein Is Posttranslationally Cleaved by Proprotein Convertase 1 to Generate Agouti-Related Protein (AGRP)83-132: Interaction between AGRP83-132 and Melanocortin Receptors Cannot Be Influenced by Syndecan-3
Endocrinology, April 1, 2006; 147(4): 1621 - 1631.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. M. Hsiung, J. Hertel, X.-y. Zhang, D. P. Smith, D. L. Smiley, M. L. Heiman, D. D. Yang, S. Husain, J. P. Mayer, L. Zhang, et al.
A Novel and Selective {beta}-Melanocyte-Stimulating Hormone-Derived Peptide Agonist for Melanocortin 4 Receptor Potently Decreased Food Intake and Body Weight Gain in Diet-Induced Obese Rats
Endocrinology, December 1, 2005; 146(12): 5257 - 5266.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R G P Denis, C Bing, S Brocklehurst, J A Harrold, R G Vernon, and G Williams
Diurnal changes in hypothalamic neuropeptide and SOCS-3 expression: effects of lactation and relationship with serum leptin and food intake
J. Endocrinol., October 1, 2004; 183(1): 173 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Santoro, E. M. del Giudice, G. Cirillo, P. Raimondo, I. Corsi, A. Amato, A. Grandone, and L. Perrone
An Insertional Polymorphism of the Proopiomelanocortin Gene Is Associated with Fasting Insulin Levels in Childhood Obesity
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4846 - 4849.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Guo, H. Munzberg, R. C. Stuart, E. A. Nillni, and C. Bjorbaek
N-acetylation of hypothalamic {alpha}-melanocyte-stimulating hormone and regulation by leptin
PNAS, August 10, 2004; 101(32): 11797 - 11802.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Jing, E. A. Nillni, V. C. Sanchez, R. C. Stuart, and D. J. Good
Deletion of the Nhlh2 Transcription Factor Decreases the Levels of the Anorexigenic Peptides {alpha} Melanocyte-Stimulating Hormone and Thyrotropin-Releasing Hormone and Implicates Prohormone Convertases I and II in Obesity
Endocrinology, April 1, 2004; 145(4): 1503 - 1513.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton
Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. H. Humphreys
{gamma}-MSH, sodium metabolism, and salt-sensitive hypertension
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2004; 286(3): R417 - R430.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Laurent, L. Jaubert-Miazza, R. Desjardins, R. Day, and I. Lindberg
Biosynthesis of Proopiomelanocortin-Derived Peptides in Prohormone Convertase 2 and 7B2 Null Mice
Endocrinology, February 1, 2004; 145(2): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
K. L.J. Ellacott and R. D. Cone
The Central Melanocortin System and the Integration of Short- and Long-term Regulators of Energy Homeostasis
Recent Prog. Horm. Res., January 1, 2004; 59(1): 395 - 408.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. J. F. Loos, P. T. Katzmarzyk, D. C. Rao, T. Rice, A. S. Leon, J. S. Skinner, J. H. Wilmore, T. Rankinen, and C. Bouchard
Genome-Wide Linkage Scan for the Metabolic Syndrome in the HERITAGE Family Study
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5935 - 5943.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Mayan, X.-P. Ni, S. Almog, and M. H. Humphreys
Suppression of {gamma}-Melanocyte-Stimulating Hormone Secretion Is Accompanied by Salt-Sensitive Hypertension in the Rat
Hypertension, November 1, 2003; 42(5): 962 - 967.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Li, C. V. Mobbs, and P. J. Scarpace
Central Pro-opiomelanocortin Gene Delivery Results in Hypophagia, Reduced Visceral Adiposity, and Improved Insulin Sensitivity in Genetically Obese Zucker Rats
Diabetes, August 1, 2003; 52(8): 1951 - 1957.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Munzberg, L. Huo, E. A. Nillni, A. N. Hollenberg, and C. Bjorbaek
Role of Signal Transducer and Activator of Transcription 3 in Regulation of Hypothalamic Proopiomelanocortin Gene Expression by Leptin
Endocrinology, May 1, 2003; 144(5): 2121 - 2131.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. E. Pritchard, R. L. Oliver, J. D. McLoughlin, S. Birtles, C. B. Lawrence, A. V. Turnbull, and A. White
Proopiomelanocortin-Derived Peptides in Rat Cerebrospinal Fluid and Hypothalamic Extracts: Evidence that Secretion Is Regulated with Respect to Energy Balance
Endocrinology, March 1, 2003; 144(3): 760 - 766.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. Gantz and T. M. Fong
The melanocortin system
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E468 - E474.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Endocrinology.